2025-08-28 23:13:51
Latest Post
Himadri Speciality Chemical Ltd Secures ISCC PLUS Certification
HCLSoftware delivers Digital Independence with AI-Powered Sovereign Collaboration Solutions for Business-Critical Infrastructure
Dr. Agarwal's Health Care Limited and Dr. Agarwal's Eye Hospital Limited announce Merger
SAMHI signs agreement to Lease for ~260-room Mid-Scale Hotel in Hyderabad's Financial District
Rail Vikas Nigam Ltd signs JV agreement with Texmaco Rail & Engineering Ltd
Stock Report
Aarey Drugs and Pharmaceuticals Ltd Q2FY22 PAT higher at Rs. 2.84 crore
Posted On : 2021-11-18 10:56:06( TIMEZONE : IST )
AAREY DRUGS & PHARMACEUTICALS LTD. has reported Standalone financial results for the period ended September 30, 2021.
Financial Results (Q2 FY2022) - QoQ Comparison
The company has reported total income of Rs. 135.4639 crores during the period ended September 30, 2021 as compared to Rs. 98.1886 crores during the period ended June 30, 2021.
The company has posted net profit / (loss) of Rs. 2.8436 crores for the period ended September 30, 2021 as against net profit / (loss) of Rs. 2.5086 crores for the period ended June 30, 2021.
The company has reported EPS of Rs. 1.22 for the period ended September 30, 2021 as compared to Rs. 1.07 for the period ended June 30, 2021.
| Financials | Q2 FY2022 | Q1 FY2022 | % Change |
| Total Income | ₹ 135.4639 crs | ₹98.1886 crs |  37.96% |
| Net Profit | ₹2.8436 crs | ₹2.5086 crs | 13.35% |
| EPS | ₹1.22 | ₹1.07 | 14.02% |
Financial Results (Q2 FY2022) - YoY Comparison
The company has reported total income of Rs. 135.4639 crores during the period ended September 30, 2021 as compared to Rs.52.3735 crores during the period ended September 30, 2020.
The company has posted net profit / (loss) of Rs.2.8436 crores for the period ended September 30, 2021 as against net profit / (loss) of Rs.1.8457 crores for the period ended September 30, 2020.
The company has reported EPS of Rs.1.22 for the period ended September 30, 2021 as compared to Rs.0.79 for the period ended September 30, 2020.
| Financials | Q2 FY2022 | Q2 FY2021 | % Change |
| Total Income | ₹ 135.4639 crs | ₹52.3735 crs | 158.65% |
| Net Profit | ₹2.8436 crs | ₹1.8457 crs | 54.07% |
| EPS | ₹1.22 | ₹0.79 | 54.43% |
Financial Results (Half Year Ended FY2022) - YoY Comparison
The company has reported total income of Rs.233.6525 crores during the 6 Months period ended September 30, 2021 as compared to Rs.78.3286 crores during the 6 Months period ended September 30, 2020.
The company has posted net profit / (loss) of Rs.5.3522 crores for the 6 Months period ended September 30, 2021 as against net profit / (loss) of Rs.3.4042 crores for the 6 Months period ended September 30, 2020.
The company has reported EPS of Rs.2.29 for the 6 Months period ended September 30, 2021 as compared to Rs.1.46 for the 6 Months period ended September 30, 2020.
| Financials | Half Year Ended FY2022 | Half Year Ended FY2021 | % Change |
| Total Income | ₹233.6525 crs | ₹78.3286 crs | 198.30% |
| Net Profit | ₹5.3522 crs | ₹3.4042 crs | 57.22% |
| EPS | ₹2.29 | ₹1.46 | 56.85% |
Shares of AAREY DRUGS & PHARMACEUTICALS LTD. was last trading in BSE at Rs. 35.65 as compared to the previous close of Rs. 36.30. The total number of shares traded during the day was 24559 in over 334 trades.
The stock hit an intraday high of Rs. 36.95 and intraday low of 35.45. The net turnover during the day was Rs. 889728.00.
